Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Minority Interest (2020 - 2025)

Apyx Medical's Minority Interest history spans 6 years, with the latest figure at $291000.0 for Q4 2025.

  • For Q4 2025, Minority Interest rose 132.8% year-over-year to $291000.0; the TTM value through Dec 2025 reached $291000.0, up 132.8%, while the annual FY2025 figure was $291000.0, 132.8% up from the prior year.
  • Minority Interest reached $291000.0 in Q4 2025 per APYX's latest filing, up from $232000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $338000.0 in Q2 2021 to a low of $125000.0 in Q4 2024.
  • Average Minority Interest over 5 years is $221950.0, with a median of $220000.0 recorded in 2022.
  • Peak YoY movement for Minority Interest: tumbled 47.21% in 2023, then surged 132.8% in 2025.
  • A 5-year view of Minority Interest shows it stood at $317000.0 in 2021, then tumbled by 30.91% to $219000.0 in 2022, then increased by 0.91% to $221000.0 in 2023, then plummeted by 43.44% to $125000.0 in 2024, then skyrocketed by 132.8% to $291000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Minority Interest are $291000.0 (Q4 2025), $232000.0 (Q3 2025), and $203000.0 (Q2 2025).